The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.42
Bid: 17.42
Ask: 18.08
Change: 0.14 (0.80%)
Spread: 0.66 (3.789%)
Open: 17.42
High: 17.42
Low: 17.42
Prev. Close: 17.61
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, Move to Main Market and Placing

22 Apr 2015 16:45

RNS Number : 0446L
Nanoco Group PLC
22 April 2015
 

 

For immediate release

22 April 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Result of General Meeting, Move to Main Market

and Placing to raise £20 million gross

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that all resolutions were duly passed at its General Meeting held earlier today in connection with the Company's proposed move from AIM to the Main Market of the London Stock Exchange and the Placing announced on 31 March 2015.

 

Following the outcome of the General Meeting, the Company will now proceed with the proposed move to the Main Market and the Placing to raise gross proceeds of £20 million.

A summary of the votes cast on the Resolutions put to Shareholders at the General Meeting is shown below:

 

Resolutions

For

Against

Withheld

Number

%

Number

%

Number

1

THAT, conditionally upon Admission, the New Articles of Association (as defined in the Circular) be approved and adopted as the new articles of association of the Company in substitution for, and to the exclusion of, the existing articles of association of the Company.

 

140,776,175

 

99.95

72,957

0.05

578

2

THAT, conditionally upon the passing of Resolution 1 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be generally and unconditionally authorised, in accordance with section 551 of the Companies Act 2006, to allot up to 19,047,619 Ordinary Shares in aggregate in the capital of the Company, such authority to expire at the end of 31 July 2015.

 

140,776,753

 

99.94

80,400

0.06

0

3

THAT, conditionally upon the passing of Resolutions 1 and 2 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be given power to allot up to 19,047,619 Ordinary Shares for cash pursuant to the authority referred to in Resolution 2 other than on a pro-rata basis to shareholders as if section 561 of the Companies Act 2006 did not apply, such authority to expire at the end of 31 July 2015.

 

140,761,553

 

99.86

 

201,664

0.14

15,200

 

The issued share capital of the Company on the date of the meeting was 217,330,383 ordinary shares of 10 pence each ("Ordinary Shares").

In accordance with the Disclosure Rules and Transparency Rules, a copy of the Resolutions proposed and passed at the General Meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM and will also be available for inspection at www.nanocotechnologies.com.

Notification of the Company's intention to de-list from AIM has been submitted to the London Stock Exchange. It is expected that the last day of dealings in the Ordinary Shares on AIM will occur on 30 April 2015.

Applications will shortly be made to the Official List and to the London Stock Exchange for 236,378,002 Ordinary Shares, fully paid and conditional upon Admission, to be admitted to listing on the premium segment of the Official List and to be admitted to trading on the Main Market. It is expected that Admission of the 236,378,002 Ordinary Shares will occur at 8.00 a.m. on 1 May 2015.

Completion of the Placing and Admission remains subject to certain conditions. A further announcement will be made in due course.

All capitalised terms in this announcement have the meaning given to them in the Circular, unless otherwise defined herein.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Nomad, Sponsor and Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUOVRVKASUAR
Date   Source Headline
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.